Skip to main content
Journal cover image

Evolving therapies, neurocognitive outcomes, and functional independence in adult survivors of childhood glioma.

Publication ,  Journal Article
Papini, C; Mirzaei S, S; Xing, M; Tonning Olsson, I; de Blank, PMK; Lange, KR; Salloum, R; Srivastava, D; Leisenring, WM; Howell, RM; Krull, KR ...
Published in: J Natl Cancer Inst
February 8, 2024

BACKGROUND: Treatment of childhood glioma has evolved to reduce radiotherapy exposure with the goal of limiting late toxicity. However, the associations between treatment changes and neurocognition, and the contribution of neurocognition and chronic health conditions to attainment of adult independence, remain unknown. METHODS: Adult survivors of childhood glioma diagnosed in 1970-1999 in the Childhood Cancer Survivor Study (n = 1284; median [minimum-maximum] 30 [18-51] years of age at assessment; 22 [15-34] years from diagnosis) self-reported neurocognitive impairment and chronic health conditions. Multivariable models evaluated associations between changes in treatment exposures (surgery only, chemotherapy [with or without surgery], cranial radiation [with or without chemotherapy and/or surgery]), and neurocognitive impairment. Latent class analysis with 5 indicators (employment, independent living, assistance with routine and/or personal care needs, driver's license, marital or partner status) identified classes of functional independence. Path analysis tested associations among treatment exposures, neurocognitive impairment, chronic health conditions, and functional independence. Statistical tests were 2-sided. RESULTS: Cranial radiation exposure decreased over time (51%, 1970s; 46%, 1980s; 27%, 1990s]. However, compared with siblings, survivors with any treatment exposure were at elevated risk for neurocognitive impairment, including surgery only (eg, memory: relative risk = 2.22; task efficiency: relative risk = 1.88; both P < .001). Three classes of functional independence were identified: independent (58%), moderately independent (20%), and nonindependent (22%). Cranial radiation was associated with nonindependence through impaired task efficiency (β = 0.06), sensorimotor (β = 0.06), and endocrine (β = 0.10) chronic health conditions and through the associations between these conditions and task efficiency (each β = 0.04). Sensorimotor and endocrine chronic health conditions were associated with nonindependence through memory. CONCLUSION: Most long-term glioma survivors achieve adult independence. However, functional nonindependence is associated with treatment-related neurocognitive impairment and chronic health conditions.

Duke Scholars

Published In

J Natl Cancer Inst

DOI

EISSN

1460-2105

Publication Date

February 8, 2024

Volume

116

Issue

2

Start / End Page

288 / 298

Location

United States

Related Subject Headings

  • Survivors
  • Outcome Assessment, Health Care
  • Oncology & Carcinogenesis
  • Humans
  • Glioma
  • Functional Status
  • Employment
  • Adult
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Papini, C., Mirzaei S, S., Xing, M., Tonning Olsson, I., de Blank, P. M. K., Lange, K. R., … Brinkman, T. M. (2024). Evolving therapies, neurocognitive outcomes, and functional independence in adult survivors of childhood glioma. J Natl Cancer Inst, 116(2), 288–298. https://doi.org/10.1093/jnci/djad190
Papini, Chiara, Sedigheh Mirzaei S, Mengqi Xing, Ingrid Tonning Olsson, Peter M. K. de Blank, Katharine R. Lange, Ralph Salloum, et al. “Evolving therapies, neurocognitive outcomes, and functional independence in adult survivors of childhood glioma.J Natl Cancer Inst 116, no. 2 (February 8, 2024): 288–98. https://doi.org/10.1093/jnci/djad190.
Papini C, Mirzaei S S, Xing M, Tonning Olsson I, de Blank PMK, Lange KR, et al. Evolving therapies, neurocognitive outcomes, and functional independence in adult survivors of childhood glioma. J Natl Cancer Inst. 2024 Feb 8;116(2):288–98.
Papini, Chiara, et al. “Evolving therapies, neurocognitive outcomes, and functional independence in adult survivors of childhood glioma.J Natl Cancer Inst, vol. 116, no. 2, Feb. 2024, pp. 288–98. Pubmed, doi:10.1093/jnci/djad190.
Papini C, Mirzaei S S, Xing M, Tonning Olsson I, de Blank PMK, Lange KR, Salloum R, Srivastava D, Leisenring WM, Howell RM, Oeffinger KC, Robison LL, Armstrong GT, Krull KR, Brinkman TM. Evolving therapies, neurocognitive outcomes, and functional independence in adult survivors of childhood glioma. J Natl Cancer Inst. 2024 Feb 8;116(2):288–298.
Journal cover image

Published In

J Natl Cancer Inst

DOI

EISSN

1460-2105

Publication Date

February 8, 2024

Volume

116

Issue

2

Start / End Page

288 / 298

Location

United States

Related Subject Headings

  • Survivors
  • Outcome Assessment, Health Care
  • Oncology & Carcinogenesis
  • Humans
  • Glioma
  • Functional Status
  • Employment
  • Adult
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis